Bio Medica Laboratories IPO Financials
The Bio Medica Laboratories IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 30 Nov 2025, Bio Medica Laboratories Limited reported assets of ₹65.17 crore, revenue of ₹28.63 crore, and a profit after tax (PAT) of ₹8.66 crore. The company had a net worth of ₹17.12 crore and reserves & surplus of ₹7.94 crore, and total borrowings are 38.17 crore.
Revenue increased by 33.88% in 31 Mar 2025 and decreased by 59.98% in 31 Mar 2024 and increased by 5.93% in 31 Mar 2023, while Profit After Tax (PAT) grew by 13.05% in 31 Mar 2025 and declined by 74.46% in 31 Mar 2024 and declined by 86.80% in 31 Mar 2023, respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Bio Medica Laboratories Limited Financials (₹ in Crores)
| Particular | 30 Nov 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 65.17 | 39.12 | 19.53 | 17.57 |
| Revenue | 28.63 | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 8.66 | 9.79 | 2.5 | 0.33 |
| Net Worth | 17.12 | 14.73 | 4.94 | 2.44 |
| Reserve & Surplus | 7.94 | 5.55 | 4.84 | 2.34 |
| Total Borrowings | 38.17 | 15.01 | 10.49 | 9.61 |
EPS Pre
10.67%
EPS Post
10.33%
P/E Pre
13.03
P/E (Post Issue)
13.45x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Bio Medica Laboratories Limited?
Bio Medica Laboratories Limited reported revenue of ₹28.63 crore as of 30 Nov 2025. Revenue figures from the Bio Medica Laboratories IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Bio Medica Laboratories Limited?
Bio Medica Laboratories Limited reported a Profit After Tax (PAT) of ₹8.66 crore as of 30 Nov 2025. PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Bio Medica Laboratories Limited?
Bio Medica Laboratories Limited has a Price-to-Earnings (P/E) ratio of 13.03x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.